|
CI26-10126
|
Innovative approach to treat Frontotemporal Dementia by eliminating pathological proteins.
|
Giuseppe Battaglia
|
Fundació Institut de Bioenginyera de Catalunya
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10149
|
Novel approach to targeting oncogenic mutations for cancer treatment.
|
Gonçalo Bernardes
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Research Consortium
|
University of Cambridge
Fundação GIMM - Gulbenkian Institute for Molecular Medicine
|
Javier Bonet-Aleta
Cong Tang
|
STAGE 1
|
Therapeutics
|
|
CI26-10166
|
Metabolic Therapy for Mitochondrial DNA Maintenance Disorders
|
Ramon Martí
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Research Consortium
|
Universitat de Barcelona
|
Marçal Pastor Anglada
|
STAGE 1
|
Therapeutics
|
|
CI26-10215
|
Biocatalytic Hubs: Enabling Rapid and Accurate Precision Management of Phenylketonuria (PKU)
|
Tiago Cordeiro
|
Universidade Nova de Lisboa
|
Research Consortium
|
FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
|
Paula Leandro
|
STAGE 1
|
Medical Devices
|
|
CI26-10257
|
A New Strategy to Fight Treatment-Resistant Cancer
|
Karmele Valencia
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10313
|
A New Strategy to Overcome Resistance to Cancer Treatment
|
Alfonso Calvo
|
Universidad de Navarra
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10395
|
DNA-Scaffolded Lateral Flow Assays: Enhancing the Accuracy of Strongyloidiasis Serological Diagnosis
|
Claudio Parolo
|
FURV-Fundació Universitat Rovira i Virgili
|
Research Consortium
|
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
Institut de Salut Global de Barcelona (ISGlobal)
|
Gabriel Ortega
Jose Muñoz
|
STAGE 1
|
Medical Devices
|
|
CI26-10426
|
A Novel Hedgehog Signaling Inhibitor for Targeted Cancer Treatment
|
Josep Roma
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10469
|
Advancing Newborn Screening for Rare Metabolic Disorders: Innovative Diagnostics for CACT Deficiency
|
Jose Luis Chiara
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Research Consortium
|
Fundación para la Investigación e Innovación Biosanitaria en el Principado de Asturias
Universidad del Pais Vasco (UPV/EHU)
|
Maria Dolores Chiara Romero
Virginia Martinez Martinez
|
STAGE 1
|
Diagnostics
|
|
CI26-10518
|
A Personalized 3D Approach to Prevent Diabetic Foot Ulcers
|
Raquel Leirós
|
Universidad de León
|
Research Consortium
|
Universidade da Coruña
Universidad de Extremadura
|
María Elena Arce
Jesús Manuel Rodríguez
|
STAGE 1
|
Medical Devices
|
|
CI26-10666
|
Correcting functional defects in pancreatic cells to treat diabetes.
|
Manuel Irimia
|
Universitat Pompeu Fabra (UPF)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10680
|
LUPIN: Making Brain-Computer Interfaces More Reliable for Rehabilitation and Assistive Care
|
Nuno Garcia
|
FCiências.ID – Associação para a Investigação e Desenvolvimento de Ciências
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Medical Devices
|
|
CI26-10681
|
Chondrogel: Rapid-Recovery Cartilage Repair for Improved Joint Health and Mobility.
|
Nuria Oliva
|
Universitat Ramon Llull
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Medical Devices
|
|
CI26-10741
|
Turning the body's attackers into guardians: ToleriGen, a precision cell therapy for Multiple Sclerosis
|
Federico Fondelli
|
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Therapeutics
|
|
CI26-10752
|
NEWTON Biotwins: Using Digital Twins to Make Cell Analysis Faster, Smarter, and More Reliable
|
Ángel Goñi
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Individual proposal
|
N/A
|
N/A
|
STAGE 1
|
Digital Health
|
|
CI26-20059
|
Low intensity focused ultrasound device to help spinal cord repair without surgery.
|
Pablo Villoslada
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Medical Devices
|
|
CI26-20062
|
Streamlined and affordable gene therapy manufacturing through advanced rAAV production platforms
|
Jose Miguel Escandell
|
Instituto de Biologia Experimental e Tecnológica
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-20123
|
Advancing Aurkine Cancer Therapeutics toward First-in-Human Clinical Trials
|
Jesús Bañales
|
Asociación Instituto de Investigación Sanitaria Biogipuzkoa
|
Research Consortium
|
Universidad del Pais Vasco (UPV/EHU)
Fundación para la Investigación Biomédica del Hospital Gregorio Marañón
Fundación Instituto de Investigación Sanitaria of the Fundación Jiménez Díaz
|
Fernando Cossío
Aitana Calvo
Angela Lamarca
|
STAGE 2
|
Therapeutics
|
|
CI26-20264
|
A Next-Generation Switchable CAR-T Platform for Safer and More Effective Cancer Treatment.
|
Rafael Moreno
|
Fundació Institut d´Investigació Biomèdica de Bellvitge (IDIBELL)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-20295
|
FLASH -CARE. Improving Safety and Reliability in Advanced Cancer Treatment
|
Faustino Gómez
|
Universidad de Santiago de Compostela
|
Research Consortium
|
Institut Curie
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Sophie Heinrich
Consuelo Guardiola
|
STAGE 2
|
Medical Devices
|
|
CI26-20644
|
New approach to classify metastatic patients enabling personalized treatments.
|
Manuel Valiente
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Diagnostics
|
|
CI26-20711
|
High-Sensitivity Liquid Biopsy for Detecting Homologous Recombination Deficiency in Cancer
|
ANA VIVANCOS
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Diagnostics
|
|
CI26-2U034
|
Enhancing Taxol Effectiveness through Targeted Modulation of the Cancer Tubulin Code
|
Sonia Silva
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Research Consortium
|
Universidade do Porto
|
Fernanda Borges
|
STAGE 2
|
Therapeutics
|
|
CI26-2U063
|
Next-Generation Implants for Osteoarthritis and Joint Damage
|
MIGUEL GAMA
|
Universidade do Minho
|
Research Consortium
|
Universidade de Aveiro
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
Universidade de Trás-os-Montes e Alto Douro
|
Florinda Mendes Costa Costa
Silvia Alexandra Rodrigues Mendes Ferreira
José Eduardo Pereira
|
STAGE 2
|
Medical Devices
|
|
CI26-2U074
|
Advancing Protection Against Klebsiella pneumoniae Infections through a Multiantigen DNA Vaccine
|
Mireia López
|
Universitat de Girona
|
Individual proposal
|
N/A
|
N/A
|
STAGE 2
|
Therapeutics
|
|
CI26-2U322
|
Innovative Approach for Non-Invasive Bladder Cancer Detection and Monitoring.
|
Raphaël Canadas
|
Universidade do Porto
|
Research Consortium
|
Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ciência - INESC TEC
|
Hélder Oliveira
|
STAGE 2
|
Diagnostics
|
|
CI26-2U369
|
Innovative Blood-Based Screening for Early Cancer Detection
|
Oscar Pozo
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Research Consortium
|
Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)
|
Adelaida García
|
STAGE 2
|
Diagnostics
|
|
CI26-30269
|
A targeted cancer immunotherapy that boosts the immune response while reducing side effects
|
Pedro Berraondo
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Therapeutics
|
|
CI26-3U433
|
Microbiome-derived metabolites for early detection of anal precancer
|
Sergio Serrano-Villar
|
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Diagnostics
|
|
CI26-3U693
|
New molecules to combat aggressive cancers
|
Marcos Malumbres
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual proposal
|
N/A
|
N/A
|
STAGE 3
|
Therapeutics
|
